StockData
SpyGlass Pharma, Inc. logo

SpyGlass Pharma, Inc. (SGP) stock

SGPNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$29.68−1.75 (-5.58%)

Close on Nov 18, 2026Market cap $992.74MP/E –Yield –

SpyGlass Pharma shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

SpyGlass Pharma's shares outstanding was 33M at Jun 30, 2026. For fiscal 2025 it was 2M, up 24.0% from the year before.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 20252M+24.0%
FY2024Dec 31, 20242M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 202633M–
Q1 FY2026Mar 31, 202620M–
Q2 FY2025Jun 30, 20252M–
Q1 FY2025Mar 31, 20252M–

More SpyGlass Pharma figures

See a number that looks wrong?